Project funding entity:
European Commission, FP7
Project description:
BlueGenics is an EU-FP7 project with the aim to combine the knowledge in marinegenomics, chemogenetics and advanced chemistry to produce recombinantly prepared novel secondarymetabolite (lead) compounds and analogous from them, as well as pharmacologically active peptides, and to bring them up to the pre-clinical, and hopefully also to the clinical studies.